Assyro AI

FDA Orange Book · active-ingredient family

Ergocalciferol

Ergocalciferol is approved as 1 brand and 13 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:DRISDOL · NDA 003444

1

Brand (NDA)

13

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · capsule

ProductApplicantApplicationTEApproved
DRISDOLRLDESJAY PHARMANDA 003444AAApproved Prior to Jan 1, 1982

Generic (ANDA) products (13)

ProductApplicantApplicationTEApproved
ERGOCALCIFEROLPURACAP PHARM LLCANDA 204276AADec 07, 2018
ERGOCALCIFEROLONESOURCE SPECIALTYANDA 090455AAAug 03, 2010
ERGOCALCIFEROLSIGMAPHARM LABS LLCANDA 091004Jul 14, 2010
ERGOCALCIFEROLSUN PHARM INDS INCANDA 040865Dec 29, 2009
ERGOCALCIFEROLCHARTWELL RXANDA 040833AAMay 20, 2009
DELTALINLILLYANDA 080884Approved Prior to Jan 1, 1982
VITAMIN DBIONPHARMAANDA 080704AAApproved Prior to Jan 1, 1982
VITAMIN DCHARTWELL MOLECULARANDA 080825Approved Prior to Jan 1, 1982
VITAMIN DCHASE CHEMANDA 080747Approved Prior to Jan 1, 1982
VITAMIN DEVERYLIFEANDA 080956Approved Prior to Jan 1, 1982
VITAMIN DIMPAX LABSANDA 080951Approved Prior to Jan 1, 1982
VITAMIN DVITARINEANDA 084053Approved Prior to Jan 1, 1982
VITAMIN DWEST WARDANDA 083102Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Ergocalciferol — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.